Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terri J Allen

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Expert Review of Cardiovascular Therapy|March 7, 2012
Novel pathways and therapies in experimental diabetic atherosclerosisChristine Koulis, Judy B de Haan, Terri J Allen
Kidney International|August 26, 2004
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetesGuorong Ma, Terri J Allen, Mark E Cooper, et al.
Diabetes|November 26, 2015
RAGE Against the ABCsTerri J Allen, Andrew J Murphy, Karin A Jandeleit-Dahm
Journal of Cell Communication and Signaling|March 3, 2010
Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytesXiaoyu Wang, Susan V McLennan, Terri J Allen, et al.
Journal of Hypertension|April 22, 2009
Eplerenone does not attenuate diabetes-associated atherosclerosisPhilip J W Koh, Audrey Koitka, Mark E Cooper, et al.
American Journal of Physiology. Cell Physiology|July 24, 2009
Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factorXiaoyu Wang, Susan V McLennan, Terri J Allen, et al.
Diabetes Research and Clinical Practice|February 1, 2003
High glucose potentiates mitogenic responses of cultured ovine coronary smooth muscle cells to platelet derived growth factor and transforming growth factor-beta1Peter J Little, Terri J Allen, Kazuhiko Hashimura, et al.
Journal of Hypertension|January 25, 2003
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrinBelinda J Davis, Zemin Cao, Marc de Gasparo, et al.
Clinical Science (London, England : 1979)|March 26, 2003
Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin systemMarkus Lassila, Belinda J Davis, Terri J Allen, et al.
Atherosclerosis|January 12, 2007
Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouseAnna C Calkin, Terri J Allen, Markus Lassila, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Expert Review of Cardiovascular Therapy|March 7, 2012
Novel pathways and therapies in experimental diabetic atherosclerosisChristine Koulis, Judy B de Haan, Terri J Allen
Kidney International|August 26, 2004
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetesGuorong Ma, Terri J Allen, Mark E Cooper, et al.
Diabetes|November 26, 2015
RAGE Against the ABCsTerri J Allen, Andrew J Murphy, Karin A Jandeleit-Dahm
Journal of Cell Communication and Signaling|March 3, 2010
Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytesXiaoyu Wang, Susan V McLennan, Terri J Allen, et al.
Journal of Hypertension|April 22, 2009
Eplerenone does not attenuate diabetes-associated atherosclerosisPhilip J W Koh, Audrey Koitka, Mark E Cooper, et al.
American Journal of Physiology. Cell Physiology|July 24, 2009
Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factorXiaoyu Wang, Susan V McLennan, Terri J Allen, et al.
Diabetes Research and Clinical Practice|February 1, 2003
High glucose potentiates mitogenic responses of cultured ovine coronary smooth muscle cells to platelet derived growth factor and transforming growth factor-beta1Peter J Little, Terri J Allen, Kazuhiko Hashimura, et al.
Journal of Hypertension|January 25, 2003
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrinBelinda J Davis, Zemin Cao, Marc de Gasparo, et al.
Clinical Science (London, England : 1979)|March 26, 2003
Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin systemMarkus Lassila, Belinda J Davis, Terri J Allen, et al.
Atherosclerosis|January 12, 2007
Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouseAnna C Calkin, Terri J Allen, Markus Lassila, et al.
Pageof 4